The weekly litigation news digest is live. Subscribe now

IP Verse

Methods Of Treating Ocular Conditions - EP3848028

The patent EP3848028 was granted to Oyster Point Pharma on Oct 16, 2024. The application was filed on Oct 19, 2015 under application number EP20212556A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3848028

OYSTER POINT PHARMA
Application Number
EP20212556A
Filing Date
Oct 19, 2015
Status
Granted And Under Opposition
Apr 27, 2024
Publication Date
Oct 16, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
HOFFMANN EITLEFeb 6, 2025HOFFMANN EITLEADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2008057938
DESCRIPTIONWO2009111550
DESCRIPTIONWO2010028011
DESCRIPTIONWO2010028033
OPPOSITIONEP1214062
OPPOSITIONUS2006084656
OPPOSITIONUS2011274628
OPPOSITIONWO2009069126
OPPOSITIONWO2016064759
SEARCHEP1214062
SEARCHWO2009069126

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents